CSL says its hemophilia B gene therapy is out of stock
CSL says its hemophilia B gene therapy is out of stock
Body unavailable. Use the original source.
CSL says its hemophilia B gene therapy is out of stock
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.